SEC 13F Intelligence

Managers / Q1 2023 · view latest →

Worth Venture Partners, LLC

CIK 0001696778 · 2 EXECUTIVE DRIVE, SUITE 515, FORT LEE, NJ, 07024 · 2125589017

Reported Value
$205M
Q1 2023
Positions
194
Filings on Record
30
2019–present window
Filed
May 15, 2023
original filing

Summary

Worth Venture Partners, LLC reported $205M in U.S.-listed holdings across 194 positions for Q1 2023.

Its largest position, Cinemark, represents 13.4% of the portfolio.

Compared with Q4 2022, the fund opened 63 new positions and exited 44.

Portfolio Metrics

Turnover
+22.6%
vs prior filed quarter
Top-10 Concentration
+38.5%
share of reported value
Largest Position
+13.4%
Cinemark
New / Exited
63 / 44
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $132MQ4 ’18Q1 ’19: $180MQ2 ’19: $181MQ3 ’19: $175MQ4 ’19: $204MQ4 ’19Q1 ’20: $162MQ2 ’20: $204MQ3 ’20: $122MQ4 ’20: $126MQ4 ’20Q1 ’21: $206MQ2 ’21: $269MQ3 ’21: $222MQ4 ’21: $202MQ4 ’21Q1 ’22: $217MQ2 ’22: $170MQ3 ’22: $163MQ4 ’22: $169MQ4 ’22Q1 ’23: $205MQ2 ’23: $184MQ3 ’23: $169MQ4 ’23: $185MQ4 ’23Q1 ’24: $15MQ2 ’24: $13MQ3 ’24: $14MQ4 ’24: $10MQ4 ’24Q1 ’25: $53MQ2 ’25: $65MQ3 ’25: $34MQ4 ’25: $14MQ4 ’25Q1 ’26: $32Mfilingsflow.com

Portfolio Composition

By security type
US DOMESTIC: 44.1%Common Stock: 43.1%Other: 6.3%GLOBAL: 3.1%REIT: 2.0%Other: 1.3%
  • US DOMESTIC · 44.1% · $90M
  • Common Stock · 43.1% · $88M
  • Other · 6.3% · $13M
  • GLOBAL · 3.1% · $6M
  • REIT · 2.0% · $4M
  • Other · 1.3% · $3M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TRANSOCEAN INCNEW+1.60M1.60M+$3M$3M
CHART INDS INCNEW+1.43M1.43M+$3M$3M
MARINUS PHARMACEUTICALS INCNEW+328.7K328.7K+$2M$2M
PATRICK INDS INCNEW+1.80M1.80M+$2M$2M
MRKMERCK & CO INCNEW+12.9K12.9K+$1M$1M
BKTIBK TECHNOLOGIES CORPORATIONNEW+416.0K416.0K+$1M$1M
BRAINSTORM CELL THERAPEUTICSNEW+358.9K358.9K+$1M$1M
CVVCVD EQUIP CORPNEW+82.1K82.1K+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2023

154 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CINEMARK HLDGS INCNOTE 4.500% 8/113.35%$27M2.15M
2PALO ALTO NETWORKS INCNOTE 0.750% 7/03.51%$7M3.21M
3UNITED STATES STL CORPNOTE 5.000%11/03.50%$7M3.51M
4BLOOMIN BRANDS INCNOTE 5.000% 5/03.31%$7M2.95M
5INDIINDIE SEMICONDUCTOR INChistory →CLASS A COM3.13%$6M608.2K
6WORLD WRESTLING ENTMT INCNOTE 3.375%12/12.73%$6M1.53M
7FTI CONSULTING INCNOTE 2.000% 8/12.34%$5M2.45M
8AVNWAVIAT NETWORKS INChistory →COM NEW2.27%$5M135.3K
9SCPHSCPHARMACEUTICALS INChistory →COM2.26%$5M510.6K
10TELATELA BIO INChistory →COM2.13%$4M409.6K
11ADTNADTRAN HOLDINGS INChistory →COM2.06%$4M265.7K
12LIVENT CORPNOTE 4.125% 7/11.78%$4M1.40M
13TGANTRANSPHORM INChistory →COM1.72%$4M884.8K
14ANIPANI PHARMACEUTICALS INChistory →COM1.66%$3M85.6K
15TRANSOCEAN INCDEB 4.625% 9/31.61%$3M1.60M
16CHART INDS INCNOTE 1.000%11/11.53%$3M1.43M
17GUESS INCNOTE 2.000% 4/11.48%$3M2.90M
18SILICOM LTDORD1.37%$3M74.9K
19BIODESIX INCCOM1.23%$3M1.36M
20PARSONS CORP DELNOTE 0.250% 8/11.14%$2M2.11M
21CAMBIUM NETWORKS CORPSHS1.13%$2M130.5K
22MARINUS PHARMACEUTICALS INCCOM NEW1.11%$2M328.7K
23ENVESTNET INCNOTE 0.750% 8/1 · COM1.09%$2M1.64M
24CTI BIOPHARMA CORPCOM1.06%$2M516.6K
25PGRPROGRESSIVE CORPhistory →COM1.05%$2M15.0K
26HGVHILTON GRAND VACATIONS INChistory →COM1.04%$2M47.9K
27FCFRANKLIN COVEY COhistory →COM1.04%$2M55.2K
28APPSDIGITAL TURBINE INChistory →COM NEW1.00%$2M166.1K
29CVNACARVANA COCL A0.95%$2M199.6K
30VERADIGM INCNOTE 0.875% 1/00.90%$2M1.63M
31LUMENTUM HLDGS INCNOTE 0.250% 3/10.90%$2M1.75M
32OMFONEMAIN HLDGS INCCOM0.88%$2M48.4K
33APOAPOLLO GLOBAL MGMT INCCOM0.85%$2M27.5K
34CALAMP CORPCOM0.84%$2M481.6K
35PARATEK PHARMACEUTICALS INCCOM0.81%$2M657.9K
36PATRICK INDS INCNOTE 1.750%12/00.81%$2M1.80M
37COFCAPITAL ONE FINL CORPCOM0.79%$2M16.7K
38CARNIVAL CORPNOTE 5.750%10/00.75%$2M1.22M
39MRAMEVERSPIN TECHNOLOGIES INCCOM0.70%$1M209.4K
40INTEGRA LIFESCIENCES HLDGS CNOTE 0.500% 8/10.69%$1M1.46M
41RJFRAYMOND JAMES FINL INCCOM0.67%$1M14.7K
42MRKMERCK & CO INCCOM0.67%$1M12.9K
43GSKGSK PLCSPONSORED ADA0.66%$1M38.3K
44IONIS PHARMACEUTICALS INCNOTE 0.125%12/10.66%$1M1.46M
45PROGRESS SOFTWARE CORPNOTE 1.000% 4/10.64%$1M1.19M
46LCI INDSNOTE 1.125% 5/10.63%$1M1.42M
47NATERA INCNOTE 2.250% 5/00.61%$1M769.0K
48MIDDLEBY CORPNOTE 1.000% 9/00.59%$1M968.0K
49BKTIBK TECHNOLOGIES CORPORATIONCOM0.58%$1M416.0K
50BRAINSTORM CELL THERAPEUTICSCOM NEW0.58%$1M358.9K
51LPTHLIGHTPATH TECHNOLOGIES INCCOM CL A0.58%$1M837.0K
52CVVCVD EQUIP CORPCOM0.53%$1M82.1K
53PFEPFIZER INCCOM0.51%$1M25.7K
54ITERIS INC NEWCOM0.49%$997,563212.7K
55WINNEBAGO INDS INCNOTE 1.500% 4/00.49%$996,567898.0K
56CGTXCOGNITION THERAPEUTICS INCCOM0.48%$993,404501.7K
57AIRGAIRGAIN INCCOM0.47%$957,514178.3K
58NUVASIVE INCNOTE 0.375% 3/10.47%$955,0961.07M
59BWENBROADWIND INCCOM NEW0.46%$944,640246.0K
60DZSIQDZS INCCOM0.44%$909,977115.3K
61INFINERA CORPCOM0.43%$888,784114.5K
62BMYBRISTOL MYERS SQUIBB COCOM0.43%$887,16812.8K
63BACBANK AMERICA CORPCOM0.43%$883,36830.9K
64PG&E CORPUNIT 08/16/20230.43%$875,6686.1K
65SCYNEXIS INCCOM NEW0.42%$855,981285.3K
66ETSY INCNOTE 0.125%10/00.41%$836,276582.0K
67LUVSOUTHWEST AIRLS COCOM0.38%$789,12824.3K
68VAREX IMAGINGCORPNOTE 4.000% 6/00.36%$747,961679.0K
69MKLMARKEL CORPCOM0.36%$742,175581
70MDNAFMEDICENNA THERAPEUTI CORPCOM0.33%$684,9751.05M
71THERATECHNOLOGIES INCCOM0.33%$684,450846.7K
72NBIXNEUROCRINE BIOSCIENCES INCCOM0.32%$647,0996.4K
73WEAVWEAVE COMMUNICATIONS INCCOM0.31%$639,644128.7K
74AMYRIS INCNOTE 1.500%11/10.29%$595,7222.01M
75MCHPMICROCHIP TECHNOLOGY INC.COM0.29%$592,3257.1K
76BOOKING HOLDINGS INCNOTE 0.750% 5/00.28%$582,970388.0K
77SPRUCE BIOSCIENCES INCCOM0.28%$581,465270.6K
78IPWRIDEAL POWER INCCOM NEW0.27%$549,54552.6K
79IMAX CORPNOTE 0.500% 4/00.27%$545,797573.0K
80COYACOYA THERAPEUTICS INCCOMMON STOCK0.26%$542,767137.8K
81Y-MABS THERAPEUTICS INCCOM0.26%$523,480104.5K
82DISH NETWORK CORPORATIONNOTE 12/10.25%$520,070966.0K
83FKWLFRANKLIN WIRELESS CORPCOM0.24%$492,15398.8K
84PURE STORAGE INCNOTE 0.125% 4/10.24%$489,474485.0K
85CELLECTAR BIOSCIENCES INCCOM NEW0.24%$484,704336.6K
86NTSTNETSTREIT CORPCOM0.23%$462,52125.3K
87CTOCTO RLTY GROWTH INC NEWCOM0.22%$453,97326.3K
88DFSCWKWESST MICRO SYSTEMS INCCOM NEW · *W EXP 12/09/2020.22%$453,847294.7K
89ABEOABEONA THERAPEUTICS INCCOM NEW0.22%$452,641160.5K
90NVECNVE CORPCOM NEW0.22%$444,6605.4K
91PTCTPTC THERAPEUTICS INCCOM0.21%$433,8299.0K
92DESKTOP METAL INCCOM CL A0.21%$424,343184.5K
93NRDYNERDY INCCL A COM0.20%$411,31298.4K
94WOLFSPEED INCCOM0.19%$396,9096.1K
95NVCRNOVOCURE LTDORD SHS0.19%$384,8966.4K
96FENCFENNEC PHARMACEUTICALS INCCOM0.18%$378,04445.4K
97APREAPREA THERAPEUTICS INCCOM0.18%$377,66784.9K
98APYXAPYX MEDICAL CORPORATIONCOM0.18%$373,740129.8K
99RVL PHARMACEUTICALS PLCSHS0.18%$368,025322.8K
100VICIVICI PPTYS INCCOM0.18%$367,20311.3K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$32M55May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$14M53Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$34M64Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$65M42Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$53M36May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$10M34Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$14M49Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$13M56Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$15M63May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$185M130Feb 9, 202413F-HRchanges · EDGAR ↗
Q3 2023$169M163Nov 15, 202313F-HRchanges · EDGAR ↗
Q2 2023$184M173Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$205M194May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$169M183Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$163M183Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$170M150Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$217M148May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$202M130Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$222M130Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$269M115Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$206M111May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$126M101Feb 17, 202113F-HRchanges · EDGAR ↗
Q3 2020$122M220Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$204M220Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$162M198May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$204M178Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$175M193Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$181M197Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$180M204May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$132M209Feb 15, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 3 additional managers.

  • DLD Asset Management, LP028-17749
  • AIGH Capital Management LLC028-20823
  • PB INVESTMENT PARTNERS, L.P.028-21878

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.